Big data modeling to predict platelet usage and minimize wastage in a tertiary care system
暂无分享,去创建一个
Leying Guan | Balasubramanian Narasimhan | Robert J. Tibshirani | Saurabh Gombar | R. Tibshirani | B. Narasimhan | G. Krishnan | Leying Guan | Xiaoying Tian | Xiaoying Tian | Allison J. Zemek | Gomathi Krishnan | Robert Scott | Tho D. Pham | T. Pham | S. Gombar | R. Scott
[1] P. Marks,et al. Maintaining a Safe Blood Supply in an Era of Emerging Pathogens. , 2016, The Journal of infectious diseases.
[2] J. Hess,et al. Will pathogen reduction of blood components harm more people than it helps in developed countries? , 2016, Transfusion.
[3] M. Nybo,et al. Prediction of bleeding and prophylactic platelet transfusions in cancer patients with thrombocytopenia , 2016, Platelets.
[4] P. Morel,et al. Improving platelet transfusion safety: biomedical and technical considerations. , 2016, Blood transfusion = Trasfusione del sangue.
[5] M. Zembala,et al. Predicting Bleeding Risk by Platelet Function Testing in Patients Undergoing Heart Surgery , 2015, Clinical cardiology.
[6] L. Estcourt. Why has demand for platelet components increased? A review , 2014, Transfusion medicine.
[7] P. Meer. Platelet concentrates, from whole blood or collected by apheresis? , 2013 .
[8] N. Tynngård. Preparation, storage and quality control of platelet concentrates. , 2009, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.
[9] B. Solheim. Pathogen reduction of blood components. , 2008, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.
[10] D. Jaspan. Erythropoietic therapy: cost efficiency and reimbursement. , 2007, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[11] Scott Murphy,et al. A critical comparison of platelet preparation methods , 2006, Current opinion in hematology.
[12] J. Epstein,et al. FDA approach to evaluation of pathogen reduction technology , 2003, Transfusion.
[13] M. Postma,et al. Cost-effectiveness of transfusion of platelet components prepared with pathogen inactivation treatment in the United States , 2003, Clinical Therapeutics.
[14] R. Cardigan,et al. The quality of platelets after storage for 7 days , 2003, Transfusion medicine.
[15] G. Grunwald,et al. Factors affecting transfusion of fresh frozen plasma, platelets, and red blood cells during elective coronary artery bypass graft surgery. , 2003, Archives of pathology & laboratory medicine.
[16] R. Dodd. Bacterial contamination and transfusion safety: experience in the United States. , 2003, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.
[17] D. Theriaque,et al. Platelet transfusions in the neonatal intensive care unit:factors predicting which patients will require multiple transfusions , 2001, Transfusion.
[18] J. Findlay,et al. Poor prediction of blood transfusion requirements in adult liver transplantations from preoperative variables. , 2000, Journal of clinical anesthesia.
[19] J. Weissfeld,et al. The cost‐effectiveness of reducing donor exposures with single‐donor versus pooled random‐donor platelets , 1999, Transfusion.
[20] D P Connelly,et al. Automatic prediction of platelet utilization by time series analysis in a large tertiary care hospital. , 1985, American journal of clinical pathology.
[21] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[22] P. F. van der Meer. Platelet concentrates, from whole blood or collected by apheresis? , 2013, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.
[23] R. Tibshirani. Regression Shrinkage and Selection via the Lasso , 1996 .